Cargando…

Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.

Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivative...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavériaux, C., Boesch, D., Boelsterli, J. J., Bollinger, P., Eberle, M. K., Hiestand, P., Payne, T., Traber, R., Wenger, R., Loor, F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247253/
https://www.ncbi.nlm.nih.gov/pubmed/2481487
_version_ 1782150942428233728
author Gavériaux, C.
Boesch, D.
Boelsterli, J. J.
Bollinger, P.
Eberle, M. K.
Hiestand, P.
Payne, T.
Traber, R.
Wenger, R.
Loor, F.
author_facet Gavériaux, C.
Boesch, D.
Boelsterli, J. J.
Bollinger, P.
Eberle, M. K.
Hiestand, P.
Payne, T.
Traber, R.
Wenger, R.
Loor, F.
author_sort Gavériaux, C.
collection PubMed
description Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivatives of cyclosporin (Cs) were compared for their ability to sensitise both parental and MDR cells to chemotherapeutic agents. Although 5-10-fold increases of sensitivity to anti-tumour drugs could be obtained for cells of the parental line with several Cs-derivatives, the largest 'gains' of sensitivity (chemosensitisation) were obtained for the cells of the MDR line and with only some of the Cs derivatives. The MDR cells employed displayed the typical MDR phenotype. However, we found no correlation between the immunosuppressive activity of Cs derivatives and their capacity to reverse MDR and all four possible combinations of these two activities could indeed be shown among the tested Cs derivatives. This study demonstrates for the first time that some immunosuppressive Cs can be devoid of chemosensitising activity.
format Text
id pubmed-2247253
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22472532009-09-10 Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. Gavériaux, C. Boesch, D. Boelsterli, J. J. Bollinger, P. Eberle, M. K. Hiestand, P. Payne, T. Traber, R. Wenger, R. Loor, F. Br J Cancer Research Article Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivatives of cyclosporin (Cs) were compared for their ability to sensitise both parental and MDR cells to chemotherapeutic agents. Although 5-10-fold increases of sensitivity to anti-tumour drugs could be obtained for cells of the parental line with several Cs-derivatives, the largest 'gains' of sensitivity (chemosensitisation) were obtained for the cells of the MDR line and with only some of the Cs derivatives. The MDR cells employed displayed the typical MDR phenotype. However, we found no correlation between the immunosuppressive activity of Cs derivatives and their capacity to reverse MDR and all four possible combinations of these two activities could indeed be shown among the tested Cs derivatives. This study demonstrates for the first time that some immunosuppressive Cs can be devoid of chemosensitising activity. Nature Publishing Group 1989-12 /pmc/articles/PMC2247253/ /pubmed/2481487 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Gavériaux, C.
Boesch, D.
Boelsterli, J. J.
Bollinger, P.
Eberle, M. K.
Hiestand, P.
Payne, T.
Traber, R.
Wenger, R.
Loor, F.
Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title_full Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title_fullStr Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title_full_unstemmed Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title_short Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
title_sort overcoming multidrug resistance in chinese hamster ovary cells in vitro by cyclosporin a (sandimmune) and non-immunosuppressive derivatives.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247253/
https://www.ncbi.nlm.nih.gov/pubmed/2481487
work_keys_str_mv AT gavariauxc overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT boeschd overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT boelsterlijj overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT bollingerp overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT eberlemk overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT hiestandp overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT paynet overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT traberr overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT wengerr overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives
AT loorf overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives